// App-Quantinova.ai

: Predictors of germline DNA damage repair gene mutations (gDDRm) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).

Researchers

Presenter

  • Steven Yip

Principal Investigators

  • Katherine Sunderland

  • Arshia Beigi

  • Arkhjamil Angeles

  • Daniel Khalaf

  • Evan W Warner

  • Gillian Vandekerkhove

  • Sophie Sun

  • Matti Annala

  • Alexander William Wyatt

  • Kim N. Chi

Medical Centers

  • BC Cancer - Vancouver Centre, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • Vancouver Prostate Centre and Department of Urologic Sciences, Vancouver, BC, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

  • Prostate cancer

  • Pancreato-biliary malignancies

Biomarkers

  • MutS protein homolog 2

  • Breast cancer type 1 susceptibility protein

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved